Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Review Article June 19 2025
Current Landscape of Frontline and Relapsed Follicular Lymphoma Trials
Research Article June 19 2025
GCK Inhibition Enhances Iberdomide Anti-Myeloma Effects by Promoting IKZF1 Degradation via a CRBN-Independent Mechanism
Brief Report June 14 2025
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy
Research Article June 9 2025
Correlates of Organ Damage in Advanced Systemic Mastocytosis Patients Enrolled in Clinical Trials of Avapritinib
Research Article June 9 2025
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: A Danish population-based study
Research Article June 9 2025
A Phase 1 Study of IO-202, an Anti-LILRB4 Antibody, in Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Research Article June 3 2025
V-FAST: A phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML
Research Article June 3 2025
Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML
Brief Report June 3 2025
Beat AML genetic risk stratification model in an older VEN/HMA-treated AML patient cohort
Research Article June 3 2025
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma.
Research Article May 19 2025
Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls
Research Article May 19 2025
Outcomes and factors influencing survival in patients with diffuse large B cell lymphoma: a population-based analysis
Research Article May 19 2025
PPARγ-induced Upregulation of Fatty Acid Metabolism Confers Resistance to Venetoclax and Decitabine Therapy in AML.
Research Article May 19 2025
NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation
Research Article May 19 2025
An Antibody-Drug Conjugate Targeting VpreB1 for the Treatment of B-cell Acute Lymphoblastic Leukemia
Research Article May 12 2025
Real world performance of the CALGB 10403 regimen in young adults in the United States
Brief Report May 11 2025
Temporal clonal relatedness between myeloid neoplasm and nodal T follicular helper cell lymphoma: a retrospective study
Research Article May 11 2025
Prognostic impact of Extranodal Disease on PET/CT in Follicular Lymphoma: Results from a Validation Study with ECOG 2408
Research Article May 11 2025
Tagraxofusp, a CD123-Targeted Therapy, for Chronic Myelomonocytic Leukemia: Final Results of a Phase 1/2 Study
Research Article May 11 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia
Research Article May 11 2025
A Comparative Assessment of Molecular-Based Prognostic Models in CMML
Research Article May 11 2025
Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCT
Research Article April 25 2025
Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
Research Article April 25 2025
The oral CDK9 inhibitor voruciclib combined with venetoclax in patients with relapsed/refractory acute myeloid leukemia
Research Article April 25 2025
Checkpoint immunotherapy is associated with preferential activation of tumor-antigen specific CD4+ T cells in MDS.
Research Article April 25 2025
Activity of STAMP inhibitors in ABL2 rearranged Acute Lymphoblastic Leukemia is dependent on the Abl2 SH3 domain
Research Article April 16 2025
Olfactory Receptors as Tumor Suppressors in Cutaneous T-Cell Lymphoma via p38γ Pathway Modulation
Research Article April 16 2025
Outcomes of Myeloablative Allogeneic Hematopoietic Cell Transplantation with Omidubicel vs Haploidentical and Unrelated Donor Sources

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals